Andy Andy is an experienced medical professional with a background in oncology and medical affairs. Currently serving as Group Medical Director in US Medical Affairs for Lung Cancer at Johnson & Johnson since April 2024, Andy previously held the position of Medical Director in the same department from June 2021 to April 2024. Prior to joining Johnson & Johnson, Andy was an Associate Director for US Medical Affairs in Analgesics/Pain at Bayer and an Associate Director for Solid Tumors in Oncology at Daiichi Sankyo, Inc. Additionally, experience includes roles as Manager of Medical Affairs for Hematology/Oncology, Nephrology, Gastroenterology, and Women's Health at American Regent, Inc., and serving as a Post-Doctoral Fellow. Andy holds a Doctor of Pharmacy degree from Long Island University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices